According to Recursion Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.34 B. In 2022 the company made an earning of -$0.24 B a decrease over its 2021 earnings that were of -$0.19 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.34 B | 38.68% |
2022 | -$0.24 B | 30.46% |
2021 | -$0.19 B | 114.28% |
2020 | -$85.65 M |